Salicylic acid

Generic name
Salicylic acid
Brand name
ATC Code
D02AF

Salicylic acid

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Hyperkeratosis
  • Cutaneous
    • 2 years up to 18 years
      • 5% or 10% ointment: Apply thinly once or twice daily
        Use a maximum of 3% for large areas.

         

Warts
  • Cutaneous
    • 1 year up to 18 years
      [2] [3]
      • Apply the 170 mg/ml application fluid or 200-400 mg/g ointment to the wart once a day so that the wart is fully covered.

      • Protect the healthy skin around the wart, for example with Vaseline.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Be aware of the possibility of resorption. Because of the risk of salicylate intoxication, salicylic acid should only be used in children on small skin areas (warts, corns). Use a maximum of 3% for large areas. Not recommended for use in children younger than 2 years. Caution is needed in children aged less than 4 years.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

EMOLLIENTS AND PROTECTIVES

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

References

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor kinderen, 2007
  2. SPC Formule W (Daro BV) juni 2008, RVG 05537
  3. GALENpharma GmbH, Verrucid® 10 % Lösung (6079295.00.00), 04/2015

Changes

Therapeutic Drug Monitoring


Overdose